<DOC>
	<DOCNO>NCT02525237</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Apatinib combine S-1 first-line therapy patient advance gastric gastroesophageal junction adenocarcinoma .</brief_summary>
	<brief_title>Apatinib Combination With S-1 First-Line Treatment Patients With Advanced Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>1 . Adult patient , age ≥18 year ; 2 . Histologically confirm adenocarcinoma stomach inoperable locally advanced recurrent and/or metastatic disease ; 3 . Measurable disease , accord Response Evaluation Criteria Solid Tumors ( RECIST v1.1 ) ; 4 . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 3 ; 5 . No previous chemotherapy advanced/metastatic disease 1 ) Prior adjuvant/neoadjuvant therapy allow least 6 month elapse completion adjuvant/neoadjuvant therapy enrolment study ) ; 2 ) No previous targeted therapy ; 3 ) For patient ca n't tolerate firstline chemotherapy refuse accept chemotherapy , request participate study , may receive apatinib monotherapy consultation principal investigator consideration ethic . 6 . Hematological , Biochemical Organ Functions : HB ≥ 80 g/L , ANC ≥ 1.5×109/L , PLT ≥ 80×109/L , BIL &lt; 1.5×ULN , ALT AST &lt; 2.5×ULN ( &lt; 5×ULN patient liver metastasis ) , Serum Cr ≤ 1×ULN , Cr clearance ≥ 50 mL/min ; 7 . Life expectancy 3 month ; 8 . Duration operation 4 week ; 9 . For woman childbearing age , pregnancy test result ( serum urine ) within 7 day enrolment must negative . They take appropriate method contraception study 8th week post last administration study drug . For men ( previous surgical sterilization accept ) , take appropriate method contraception study 8th week post last administration study drug . 10 . Signed informed consent . 1 . Patients poorcontrolled arterial hypertension ( systolic blood pressure &gt; 140 mmHg diastolic blood pressure &gt; 90 mm Hg ) despite standard medical management ; Coronary heart disease , arrhythmia ( include QT interval prolongation , man &gt; 450 m , woman &gt; 470 m ) , cardiac dysfunction great Class II ; 2 . Factors affect oral medication , inability swallow , chronic diarrhea intestinal obstruction ; 3 . Patients clear tendency gastrointestinal bleeding ; 4 . Abnormal coagulation function ( INR &gt; 1.5×ULN , APTT &gt; 1.5×ULN ) , tendency bleed ; 5 . Pregnant lactating woman ; 6 . Other condition regiment investigator ' discretion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>